Acute respiratory effect of transpyloric feeding for respiratory exacerbation in preterm infants

J Perinat Med. 2020 Nov 11;49(3):383-387. doi: 10.1515/jpm-2020-0243. Print 2021 Mar 26.

Abstract

Objectives: Gastroesophageal reflux may exacerbate chronic lung disease in preterm infants. We evaluated the short-term effects of transpyloric feeding on respiratory status in preterm infants during mechanical ventilation.

Methods: We retrospectively collected data from the hospital information management system. To evaluate the effect of transpyloric feeding on oxygenation, we compared changes in SpO2/FiO2 ratios before and after commencing transpyloric feeding by a piecewise linear regression model.

Results: We examined 33 infants (median gestational age, 25.4 weeks; median birth weight, 656 g) who underwent transpyloric feeding. All tubes were placed at the bedside without fluoroscopy. No cases of unsuccessful placement, gastroduodenal perforation, or tracheal misinsertion occurred. Transpyloric feeding began at a median age of 18 (interquartile range, 15-23) days. Mean SpO2/FiO2 (±SD) ratios were 391 (±49), 371 (±51), 365 (±56), and 366 (±53) 72-96 h before, 0-24 h before, 48-72 h after, and 96-120 h after starting transpyloric feeding, respectively. The rate of change per hour of SpO2/FiO2 ratios increased 48-120 h after compared with 0-96 h before transpyloric feeding (0.03 [95% confidence interval, -0.10 to 0.17] vs. -0.29 [-0.47 to -0.12]) (p=0.007). No apparent changes occurred in the mean airway pressure, amplitude pressure, or pCO2.

Conclusions: Transpyloric feeding during mechanical ventilation can prevent the deterioration of oxygenation without major complications at the stage of respiratory exacerbation in preterm infants.

Keywords: SpO2/FiO2 ratio; aspiration; chronic lung disease; gastric feeding; gastroesophageal reflux.

MeSH terms

  • Disease Progression
  • Enteral Nutrition* / adverse effects
  • Enteral Nutrition* / instrumentation
  • Enteral Nutrition* / methods
  • Female
  • Gastroesophageal Reflux* / complications
  • Gastroesophageal Reflux* / therapy
  • Gestational Age
  • Humans
  • Hypoxia* / diagnosis
  • Hypoxia* / etiology
  • Hypoxia* / prevention & control
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases* / epidemiology
  • Infant, Premature, Diseases* / physiopathology
  • Infant, Premature, Diseases* / therapy
  • Japan / epidemiology
  • Lung Diseases* / physiopathology
  • Lung Diseases* / therapy
  • Male
  • Point-of-Care Systems
  • Respiration, Artificial* / adverse effects
  • Respiration, Artificial* / methods
  • Risk Adjustment / methods
  • Treatment Outcome